Pancreatic Cancer Research

ResearcherSichuan UniversityNo recent work listed

Ji Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6769-3425; OpenAlex author ID A5100396325. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. Copper deprivation enhances the chemosensitivity of pancreatic cancer to rapamycin by mTORC1/2 inhibition. Last author DOI 10.1016/j.cbi.2023.110546↗
  2. Spatially targeting and regulating tumor-associated macrophages using a raspberry-like micellar system sensitizes pancreatic cancer chemoimmunotherapy. Co-author DOI 10.1039/d2nr03053e↗
  3. [Inhibition of Copper Transporter-1 by Ammonium Tetrathiocarbolybdate in the Treatment of Pancreatic Cancer]. Last author DOI 10.12182/20200960101↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nengwen Ke · 2 shared papers, 2020–2023 · strength 0.26
  2. Ruiman Geng · 2 shared papers, 2020–2023 · strength 0.26
  3. Ting Li · 1 shared paper, 2022 · strength 0.15
  4. Man Li · 1 shared paper, 2022 · strength 0.15
  5. Qin Shu He · 1 shared paper, 2022 · strength 0.15
  6. Ziyao Wang · 1 shared paper, 2023 · strength 0.14
  7. Xubao Liu · 1 shared paper, 2023 · strength 0.14
  8. Yu Mou · 1 shared paper, 2023 · strength 0.14
  9. Huawei Cai · 1 shared paper, 2023 · strength 0.14
  10. Ya-Nan Zhao · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.